Loading...
Loading...
Application UK00912937751 · Dead
| Application Number | UK00912937751 |
| Status | Dead |
| Owner | LABCO DIAGNOSTICS ESPAÑA, S.A. |
| Filed | 2014-06-04 |
| Registered | 2014-10-30 |
| Renewal Due | 2024-06-04 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
LABCO PRENATAL TEST has a current status of Dead.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Goods, reagents and preparations for use in medical diagnosis; Reagents for use in prenatal foetal testing; Reagents for use in diagnostic pregnancy tests; Pregnancy (Chemical preparations for the diagnosis of -); Ovulation test kits and In vitro tests for sex prediction; Indicators for medical diagnosis; Diagnostic preparations; Antiserums for diagnostic purposes; Diagnostic agents for pharmaceutical use; Diagnostic preparations; Preparations for the diagnosis of ovulation; Diagnostic testing materials for medical use; Radio-isotope markers for therapeutic or diagnostic use; Medicines for human purposes; Disinfectants for medical instruments; Chemical preparations for medical purposes; Enzyme preparations for medical purposes; Chromatographic supports for medical use; Pharmaceutical and veterinary preparations; Sanitary preparations for medical purposes; Foods and dietetic substances adapted for medical use; Food for babies; Food supplements for human beings; Plasters, materials for dressings; Material for stopping teeth, dental wax; Disinfectants.
Publication of books, magazines (periodicals) and other publications; Publication of medical texts; Publishing by electronic means; Cultural awareness campaigns in the clinical, medical and scientific sectors; Specialisation courses for medical analysis; Providing of training relating to hygiene, analysis and diagnosis; Organisation of symposiums, conferences, seminars and competitions relating to education in the clinical, medical and scientific analysis sectors.
Medical, pharmaceutical, chemical, biological, bacteriological and scientific laboratories; Laboratory testing services; Laboratory research; Laboratory testing services; Clinical analysis, namely prenatal molecular karyotyping, dry eye syndrome, oxidative stress analytical profiling, early detection of cervical cancer, DNA testing for determining barcodes, ageing immunity profiling; Clinical analysis for simultaneous evaluation of 112 allergenic proteins, testing for allergies in the blood, analysis of minerals in the hair, nutritional status and oxidative stress, pharmacogenetics and bowel cancer, pharmacogenetics and breast cancer; DNA testing for determining biological paternity; Foetal DNA testing for ascertaining the sex of a baby via maternal blood samples, ophthalmological autologous serum analysis; Computer aided diagnostic testing services; Laboratory research relating to pharmaceutical preparations; Scientific and laboratory research; Chemical research and analysis services; Working on and evaluation of chemical analyses; Biochemical analysis; Chemical analysis for use in evaluations; Laboratory testing services, Material testing, Structural and functional analysis of genomes, Clinical trials, Bacteriological research; Biological research; Scientific research; Cosmetic research; Physics [research]; Chemical research; Technical research; Research and development for others; Chemistry services; Scientific information, consultancy and advice; Laboratory (Scientific -) services; Computer programming in the medical field; Rental of laboratory apparatus and instruments; Calibration services relating to medical apparatus; Quality control services.
Medical analysis services; Health clinic services [medical]; Anatomical pathology; Services for the testing of blood; Collection and preservation of human blood (blood banks) and stem cells (stem cell banks); Genetic testing for medical purposes; Prenatal testing (genetic analysis for medical purposes); Drafting of acknowledgements and diagnoses in all medical fields; Medical services for the diagnosis of conditions of the human body; Medical hygiene evaluations, including food intolerance analyses; Evaluation of fatty acid profiles; Early diagnosis of Alzheimer's disease; Genetic evaluation of diseases that commonly affect adults; Evaluation of cerebral nutrition; Evaluation of mutations in BRCA1 and BRCA2 genes; Genetic evaluation of the predisposition to cardiovascular disease; Clinical-genetic evaluation of real cardiovascular risk; Biochemical cardiovascular risk evaluation; Nutritional evaluation of skin ageing; Liver detoxification; Evaluation of the intestinal flora; Overall genetic drug response evaluation; Genetic evaluation of the predisposition to pseudoexfoliative glaucoma; Evaluation of biological age; Evaluation of oestrogen metabolism; Genetic evaluation of the predisposition to age-related macular degeneration; Genetic evaluation of the effects on foodstuffs on our health, nutritional status and oxidative stress; Genetic evaluation of the predisposition to obesity and other related diseases; Genetic evaluation of the predisposition to osteoporosis; Detection of prostate cancer; Evaluation of leaky gut syndrome; Early detection of bowel cancer in the blood; Genetic evaluation of sporting performance; Genetic evaluation of advanced sporting performance; Genetic evaluation of predisposition of thromboembolic diseases; Evaluation of the immune system; Services for the preparation of medical reports; Medical examination of individuals (Provision of reports relating to the -); Updating of personal medical history registers and archives, analysis of human tissue for medical treatment; Analysis of human serum for medical treatment; Advice relating to medical instruments, problems and services; Medical services, namely in-vitro fertilisation; Residential medical treatment services; Performing diagnosis of diseases; Medical services for the diagnosis and treatment of the human body; Surgical diagnostic services; Medical services for treatment of the skin; Paramedical services; Rental of medical equipment and sanitary installations; Rental of medical x-ray apparatus; Rental of apparatus, instruments and machines for medical purposes; Medical equipment rental; Rental of ultrasonic diagnostic apparatus, application of medical treatment; provision of medical advice and counselling; Health centers; Issuing of medical reports; Planning and booking of medical treatment; Aromatherapy services; Pharmaceutical consultation; Advisory services relating to health; Medical assistance; Blood bank services; Health centers; Plastic surgery; Medical clinic services; Nursing, medical; Pharmacists' services to make up prescriptions; In vitro fertilization services; Physical therapy; Hospitals; Hair implantation; Artificial insemination services; Massage; Dentistry; Midwife services; Chiropractics; Rehabilitation for substance abuse patients; Nursing homes; Health care; Nursing homes; Sauna services; Alternative medicine services; Opticians' services; Speech therapy services; Solarium services; Health spa services; Telemedicine services; Therapy services.
'LABCO PRENATAL TEST' is a dead trademark on the UK IPO register, owned by LABCO DIAGNOSTICS ESPAÑA, S.A.. The application (UK00912937751) was filed on 4 June 2014 and registered on 30 October 2014. The registration is set to expire on 4 June 2024.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 41 (education, entertainment & sporting services); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services).
The trademark is represented by LERROUX.
UK trademark UK00912937751 for the mark 'LABCO PRENATAL TEST' in Class 5, 41, 42, 44 is recorded on the UK IPO register as owned by LABCO DIAGNOSTICS ESPAÑA, S.A.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
No — the UK IPO records the status of UK trademark UK00912937751 for the mark 'LABCO PRENATAL TEST' as dead.
UK trademark UK00912937751 for the mark 'LABCO PRENATAL TEST' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 41 (education, entertainment & sporting services); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 5: Goods, reagents and preparations for use in medical diagnosis; Reagents for use in prenatal foetal testing; Reagents for use in diagnostic pregnancy tests; Pregnancy (Chemical preparations for the diagnosis of -); Ovulation test kits and In vitro tests for sex prediction; Indicators for medical diagnosis; D…
UK trademark UK00912937751 for the mark 'LABCO PRENATAL TEST' was filed at the UK IPO on 4 June 2014 and registered on 30 October 2014.
UK trademark UK00912937751 for the mark 'LABCO PRENATAL TEST' is currently recorded as valid until 4 June 2024, at which point it will need to be renewed with the UK IPO to remain in force.
LERROUX is listed as the attorney / representative of record for UK trademark UK00912937751 for the mark 'LABCO PRENATAL TEST' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.